Potential of Pterostilbene as an Antioxidant Therapy for Delaying Retinal Damage in Diabetic Retinopathy
Antioxidants · 20.02.2025 · 14 (3) · 244
DOI: 10.3390/antiox14030244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.02.2025. Verfasst von Raquel Burggraaf-Sánchez de Las Matas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Sagunto, Ramón y Cajal Av. s/n, 46520 Sagunto, Spain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de València, University of Valencia.
Abstract (Originalsprache)
Chronic hyperglycemia is a major driver of neurovascular damage in diabetic retinopathy (DR), a leading cause of preventable blindness in adults. DR progression is often undetected until its advanced stages, with oxidative stress recognized as a primary contributor. In diabetes, oxidative stress disrupts retinal cellular balance, damaging proteins, DNA, and lipids, and triggering photoreceptor degeneration. Pterostilbene (Pter), a polyphenol with antioxidant properties, has demonstrated protective effects in DR animal models and was assessed in a pilot clinical study. DR patients treated with 250 mg/day of oral Pter showed a reduction in the development of retinal vascular alterations characteristic of the disease. Urinary analyses confirmed Pter’s role in reducing the lipid peroxidation of polyunsaturated fatty acids (PUFAs), including arachidonic and adrenic acids, indicators of oxidative damage in DR. Pter also improved the GSH/GSSG ratio, reflecting a restored redox balance. However, after six months without treatment, retinal damage indicators reappeared, highlighting the importance of sustained intervention. These findings suggest that Pter may help slow the progression of DR by protecting against oxidative stress and highlight the importance of implementing antioxidant therapies from the diagnosis of diabetes, although its long-term impact and the development of consistent biomarkers deserve more research to optimize DR management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital of Sagunto, Ramón y Cajal Av. s/n, 46520 Sagunto, Spain.
- Department of Physiology, Faculty of Pharmacy, University of Valencia, Vicente Andrés Estellés Av. s/n, 46100 Burjassot, Spain.
- Cavanilles Institute of Biodiversity and Evolutionary Biology, University of Valencia, Catedrático José Beltrán Martínez st, 46980 Paterna, Spain.
- Vitreo-Retina Unit, Fundación de Oftalmología Médica de la Comunidad Valenciana (FOM), Pío Baroja st 12, 46015 Valencia, Spain.
- Department of Medicine and Surgery, Faculty of Health sciences, Universidad CEU Cardenal Herrera, Luis Vives st 1, 46115 Alfara del Patriarca, Spain.
- Institut des Biomolécules Max Mousseron (IBMM), Pôle Chimie Balard Recherche, UMR 5247, Université de Montpellier, CNRS, ENSCM, 340093 Montpellier, France.
ORCID-Profile: Raquel Burggraaf-Sánchez de Las Matas, Isabel Torres-Cuevas, Iván Millán, María Del Carmen Desco, Miguel Asensi, Camille Oger, Thierry Durand, Ángel Luis Ortega
Förderung
- Universitat de València
- University of Valencia
Zitieren
APA
Burggraaf-Sánchez de Las Matas, R., Torres-Cuevas, I., Millán, I., Desco, M. D. C., Oblaré-Delgado, C., Asensi, M., Mena-Mollá, S., Oger, C., Galano, J. M., Durand, T., & Ortega, Á. L. (2025). Potential of Pterostilbene as an Antioxidant Therapy for Delaying Retinal Damage in Diabetic Retinopathy. Antioxidants, 14(3), 244. https://doi.org/10.3390/antiox14030244
Vancouver
Burggraaf-Sánchez de Las Matas R, Torres-Cuevas I, Millán I, Desco MDC, Oblaré-Delgado C, Asensi M, et al. Potential of Pterostilbene as an Antioxidant Therapy for Delaying Retinal Damage in Diabetic Retinopathy. Antioxidants. 2025;14(3):244. doi:10.3390/antiox14030244
BibTeX
@article{BurggraafSnchezdeLasMatas2025,
author = {Burggraaf-Sánchez de Las Matas, Raquel and Torres-Cuevas, Isabel and Millán, Iván and Desco, María Del Carmen and Oblaré-Delgado, Candela and Asensi, Miguel and Mena-Mollá, Salvador and Oger, Camille and Galano, Jean-Marie and Durand, Thierry and Ortega, Ángel Luis},
title = {Potential of Pterostilbene as an Antioxidant Therapy for Delaying Retinal Damage in Diabetic Retinopathy},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {3},
pages = {244},
doi = {10.3390/antiox14030244}
}
EUVIMED